Taysha Gene Therapies, Inc. short interest in 2025
In 2025, Taysha Gene Therapies, Inc.'s disclosed short interest ran from 11.68% of shares outstanding on 15 Jan 2025 to 20.46% on 31 Dec 2025, a change of +8.78 percentage points. The year's high was 21.44% on 15 Jul 2025 and its low 10.55% on 31 Mar 2025, averaging 15.28% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.26 days on 15 Jul 2025. Full history: Taysha Gene Therapies, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 11.68% (15 Jan 2025)
- End of year
- 20.46% (31 Dec 2025)
- Change
- +8.78 pp
- High
- 21.44% (15 Jul 2025)
- Low
- 10.55% (31 Mar 2025)
- Average
- 15.28%
- Highest days to cover
- 18.26 (15 Jul 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 11.68% | 11.41 | |
| 31 Jan 2025 | 11.75% | 10.88 | |
| 14 Feb 2025 | 12.24% | 11.27 | |
| 28 Feb 2025 | 12.45% | 15.45 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 12.32% | 17.05 | |
| 31 Mar 2025 | 10.55% | 7.78 | |
| 15 Apr 2025 | 11.29% | 12.35 | |
| 30 Apr 2025 | 12.71% | 11.62 | |
| 15 May 2025 | 12.80% | 5.70 | 10-Q filed, results (8-K) |
| 30 May 2025 | 15.60% | 5.49 | |
| 13 Jun 2025 | 16.23% | 7.89 | |
| 30 Jun 2025 | 19.44% | 12.18 | |
| 15 Jul 2025 | 21.44% | 18.26 | |
| 31 Jul 2025 | 18.64% | 13.71 | |
| 15 Aug 2025 | 13.35% | 12.98 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 14.95% | 15.09 | |
| 15 Sep 2025 | 15.89% | 10.08 | |
| 30 Sep 2025 | 18.16% | 11.24 | |
| 15 Oct 2025 | 15.39% | 2.43 | |
| 31 Oct 2025 | 16.26% | 11.57 | |
| 14 Nov 2025 | 17.55% | 10.89 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 17.90% | 15.03 | |
| 15 Dec 2025 | 17.74% | 13.28 | |
| 31 Dec 2025 | 20.46% | 17.59 |
See also: Taysha Gene Therapies, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.